Emmaus Life Sciences, Inc.
EMMA
$0.016
$0.00053.23%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.75M | 1.83M | -2.18M | -4.35M | 1.21M |
| Total Depreciation and Amortization | 5.00K | 5.00K | 6.00K | 6.00K | 6.00K |
| Total Amortization of Deferred Charges | 76.00K | 69.00K | 69.00K | 494.00K | 719.00K |
| Total Other Non-Cash Items | -710.00K | -1.94M | 1.93M | -48.00K | -1.70M |
| Change in Net Operating Assets | 2.72M | 182.00K | -2.74M | 4.04M | 805.00K |
| Cash from Operations | 343.00K | 148.00K | -2.92M | 140.00K | 1.04M |
| Capital Expenditure | -2.00K | 1.00K | -3.00K | -4.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 2.51M | -- | 0.00 |
| Cash from Investing | -2.00K | 1.00K | 2.51M | -4.00K | -6.00K |
| Total Debt Issued | 910.00K | 800.00K | 1.00M | 1.40M | 2.04M |
| Total Debt Repaid | -1.11M | -1.24M | -766.00K | -2.36M | -2.05M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -195.00K | -438.00K | 235.00K | -955.00K | -5.00K |
| Foreign Exchange rate Adjustments | -12.00K | 19.00K | -10.00K | -16.00K | 17.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.00K | -270.00K | -187.00K | -835.00K | 1.04M |